Sumitomo Chemical India quarterly results

Q2 FY27 · Jul–Sep 2026

₹ crore	Q2 FY27	Q2 FY26	Change
Revenue	907	930	−2.4%
EBITDA	186	218	−14.8%
EBITDA margin	20.5%	23.5%	−3.0 pts
Profit before tax	210	238	−11.6%
Net profit	157	178	−11.5%
EPS	₹3.14	₹3.56	−11.8%

Every quarter

₹ crore except per share

Tap a line for its trend	Q2 FY27Sep 2026	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Earlier quartersAlpha Plus

Expenses
	907	1,063	684	568	930	1,057	679	642	988	839	674	542	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	43.6	47.3	32.2	37.0	38.8	38.8	31.6	31.2	31.2	26.0	26.7	26.9
	951	1,111	716	605	969	1,096	711	673	1,020	865	701	569
	439	554	420	331	455	445	420	334	453	385	392	231
	59.4	132	39.0	13.5	70.5	112	73.2	79.8	86.7	75.8	76.9	78.4
	39.9	−40.0	−64.2	−45.7	3.8	97.9	−85.6	−42.7	27.8	51.7	−75.9	17.1
	70.2	73.2	68.0	65.4	69.5	70.8	64.7	68.3	66.1	65.5	59.2	53.9
	1.9	2.0	1.9	2.0	2.2	1.7	1.7	1.8	1.2	1.2	1.3	1.2
	17.3	17.2	16.9	16.7	16.8	15.7	16.4	19.1	15.7	14.9	16.8	16.1
	113	110	86.7	104	113	112	87.7	96.1	109	99.8	82.1	95.8
	741	849	568	487	731	855	578	557	760	694	552	494
	186	233	134	99.5	218	219	120	106	245	161	140	65.8
	169	216	117	82.7	201	203	103	87.1	230	146	123	49.7
Profit
	210	261	148	118	238	241	133	117	260	171	149	75.4
	0.0	26.9	0.0	−16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	210	288	148	102	238	241	133	117	260	171	149	75.4
	55.2	74.3	37.3	25.8	59.2	62.1	30.9	28.2	66.1	43.6	35.3	18.3
	−2.4	−0.6	−1.1	−0.0	0.9	0.4	2.4	0.8	0.9	0.8	3.6	2.3
	52.8	73.7	36.2	25.8	60.1	62.5	33.3	29.1	67.0	44.4	38.9	20.6
	157	215	111	75.8	178	178	99.8	87.4	193	127	110	54.7
	157	215	111	75.8	178	178	99.8	87.4	193	127	110	54.7
	0.9	−1.0	0.3	5.2	1.4	−1.3	0.0	1.1	−2.5	0.4	−0.0	0.6
	158	214	112	81.0	179	177	99.8	88.5	190	127	110	55.4
	157	215	111	75.6	178	178	99.6	87.0	192	127	110	54.7
	0.2	−0.3	0.1	0.2	−0.0	−0.2	0.2	0.5	0.3	0.0	0.2	0.0
Per share
	₹3.14	₹4.30	₹2.23	₹1.52	₹3.56	₹3.57	₹2.00	₹1.74	₹3.85	₹2.54	₹2.20	₹1.10
	₹3.14	₹0.00	₹2.23	₹0.00	₹3.56	₹0.00	₹2.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00
Other comprehensive income — detail
	0.9	−1.0	0.3	5.2	1.4	−1.3	0.0	—	—	—	—	—
	1.2	−1.3	0.4	7.0	1.7	−1.8	0.2	1.2	−3.3	0.6	0.1	0.9
	0.3	−0.3	0.1	1.8	0.4	−0.5	0.0	—	—	—	—	—
	—	—	—	—	—	—	—	0.3	−0.8	0.2	0.1	0.2
	0.0	−0.0	0.0	0.0	0.1	0.0	−0.1	—	−0.0	−0.0	−0.0	—
	—	—	—	—	—	—	—	−0.2	0.0	0.0	0.0	0.0
	159	213	112	—	—	177	99.7	88.1	190	127	110	55.4
	0.2	−0.3	0.2	—	—	−0.3	0.2	0.5	0.2	0.0	0.1	0.0
Per share — as-filed variants
	₹3.14	₹4.30	₹2.23	₹1.52	₹3.56	₹3.57	₹2.00	₹1.74	₹3.85	₹2.54	₹2.20	₹1.10
	₹3.14	₹0.00	₹2.23	₹0.00	₹3.56	₹0.00	₹2.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	369	417	289	269	401	402	272	271	421	326	281	215
	40.7%	39.2%	42.3%	47.4%	43.1%	38.1%	40.0%	42.1%	42.6%	38.9%	41.7%	39.8%
Adjusted (ex-exceptional items) — derived
	210	261	148	118	238	241	133	117	260	171	149	75.4
	0.0	26.9	0.0	−16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
	157	194	111	87.8	178	178	99.8	87.4	193	127	110	54.7
	₹3.14	₹3.90	₹2.23	₹1.76	₹3.56	₹3.57	₹2.00	₹1.74	₹3.85	₹2.54	₹2.20	₹1.10

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SUMICHEM₹331.90

Sumitomo Chemical India Ltd.

· Chemicals

Annual Quarterly₹ CrorePeersBAYERCROP RALLIS PIIND SPLPETRO INDOBORAX IGPL OAL PCBLMcap ₹16,567 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Revenue from Operations	542.0	674.2	838.9	988.3	641.9	679.4	1,056.8	929.8	568.0	683.7	1,063.3	907.3
Other Income	26.9	26.7	26.0	31.2	31.2	31.6	38.8	38.8	37.0	32.2	47.3	43.6
Total Income	568.9	700.9	864.9	1,019.5	673.2	711.0	1,095.6	968.6	604.9	715.9	1,110.6	950.9
Expenses
+ Cost of Materials Consumed	231.0	391.8	384.9	453.1	334.3	419.8	444.9	454.9	331.1	420.0	554.3	439.0
+ Purchases of Stock-in-Trade	78.4	76.9	75.8	86.7	79.8	73.2	111.6	70.5	13.5	39.0	132.3	59.4
+ Changes in Inventories	17.1	-75.9	51.7	27.8	-42.7	-85.6	97.9	3.8	-45.7	-64.2	-40.0	39.9
+ Employee Benefit Expense	53.9	59.2	65.5	66.1	68.3	64.7	70.8	69.5	65.4	68.0	73.2	70.2
+ Finance Costs	1.2	1.3	1.2	1.2	1.8	1.7	1.7	2.2	2.0	1.9	2.0	1.9
+ Depreciation & Amortisation	16.1	16.8	14.9	15.7	19.1	16.4	15.7	16.8	16.7	16.9	17.2	17.3
+ Other Expenses	95.8	82.1	99.8	109.3	96.1	87.7	112.3	113.0	104.1	86.7	110.2	113.1
Total Expenses	493.5	552.1	693.8	760.0	556.7	577.9	855.0	730.8	487.3	568.4	849.3	740.7
EBITDA	65.8	140.2	161.1	245.3	106.1	119.6	219.2	218.0	99.5	134.2	233.3	185.8
EBIT	49.7	123.4	146.2	229.6	87.1	103.1	203.5	201.3	82.7	117.3	216.1	168.5
Profit
PBT before Exceptional Items	75.4	148.8	171.1	259.6	116.5	133.1	240.6	237.8	117.7	147.5	261.3	210.2
+ Exceptional Items	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-16.1	0.0	26.9	0.0
Pretax Income	75.4	148.8	171.1	259.6	116.5	133.1	240.6	237.8	101.6	147.6	288.2	210.2
+ Current Tax	18.3	35.3	43.6	66.1	28.2	30.9	62.1	59.2	25.8	37.3	74.3	55.2
+ Deferred Tax	2.3	3.6	0.8	0.9	0.8	2.4	0.4	0.9	-0.0	-1.1	-0.6	-2.4
Tax Expense	20.6	38.9	44.4	67.0	29.1	33.3	62.5	60.1	25.8	36.2	73.7	52.8
Net Income	54.7	109.9	126.7	192.5	87.4	99.8	178.1	177.8	75.8	111.3	214.5	157.4
+ Net Income — Continuing Ops	54.7	109.9	126.7	192.5	87.4	99.8	178.1	177.8	75.8	111.3	214.5	157.4
+ Other Comprehensive Income	0.6	-0.0	0.4	-2.5	1.1	0.0	-1.3	1.4	5.2	0.3	-1.0	0.9
Total Comprehensive Income	55.4	109.9	127.1	190.0	88.5	99.8	176.8	179.2	81.0	111.6	213.5	158.3
Net Income to Common	54.7	109.7	126.7	192.3	87.0	99.6	178.3	177.8	75.6	111.2	214.8	157.2
Minority Interest	0.0	0.2	0.0	0.3	0.5	0.2	-0.2	-0.0	0.2	0.1	-0.3	0.2
Per Share
Basic EPS	1.10	2.20	2.54	3.85	1.74	2.00	3.57	3.56	1.52	2.23	4.30	3.14
Diluted EPS	0.00	0.00	0.00	0.00	0.00	2.00	0.00	3.56	0.00	2.23	0.00	3.14
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	0.0	-1.3	1.4	5.2	0.3	-1.0	0.9
+ Items NOT to be Reclassified to P&L	0.9	0.1	0.6	-3.3	1.2	0.2	-1.8	1.7	7.0	0.4	-1.3	1.2
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	0.0	-0.5	0.4	1.8	0.1	-0.3	0.3
+ Tax on Items NOT to be Reclassified — alt tag	0.2	0.1	0.2	-0.8	0.3	—	—	—	—	—	—	—
+ Items to be Reclassified to P&L	—	-0.0	-0.0	-0.0	—	-0.1	0.0	0.1	0.0	0.0	-0.0	0.0
+ Tax on Items to be Reclassified — alt tag	0.0	0.0	0.0	0.0	-0.2	—	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	55.4	109.7	127.1	189.8	88.1	99.7	177.0	—	—	111.7	212.8	159.0
Comprehensive Income — Non-controlling Interests	0.0	0.1	0.0	0.2	0.5	0.2	-0.3	—	—	0.2	-0.3	0.2
Per Share — as-filed variants
Basic EPS — Continuing Operations	1.10	2.20	2.54	3.85	1.74	2.00	3.57	3.56	1.52	2.23	4.30	3.14
Diluted EPS — Continuing Operations	0.00	0.00	0.00	0.00	0.00	2.00	0.00	3.56	0.00	2.23	0.00	3.14
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	215.5	281.5	326.4	420.7	270.5	272.0	402.4	400.6	269.0	288.9	416.7	369.1
Gross Margin %	39.76	41.75	38.91	42.56	42.15	40.03	38.07	43.08	47.37	42.26	39.19	40.68
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	75.4	148.8	171.1	259.6	116.5	133.1	240.6	237.8	117.7	147.5	261.3	210.2
− Exceptional Items (reconciliation)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-16.1	0.0	26.9	0.0
Net Income Adj (tax-effected)	54.7	109.9	126.7	192.5	87.4	99.8	178.1	177.8	87.8	111.3	194.5	157.4
EPS Adj	1.10	2.20	2.54	3.85	1.74	2.00	3.57	3.56	1.76	2.23	3.90	3.14
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	499.1	499.1	499.1	499.1	499.1	499.1	499.1	499.1	499.1	499.1	499.1	499.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q2 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Sumitomo Chemical India Q2 FY27 results (July–September 2026)

Filed with NSE on Monday, 26 October 2026 at 3:50 pm IST

Sumitomo Chemical India (NSE: SUMICHEM) reported its Q2 FY27 results (July–September 2026) on Monday, 26 October 2026 at 3:50 pm IST. Consolidated net profit was ₹157 crore, down 11.5% from ₹178 crore in Q2 FY26 and down 26.8% from ₹215 crore in Q1 FY27. Revenue from operations was ₹907 crore, down 2.4% year on year and down 14.7% from the previous quarter.

Q2 FY26 results (a year earlier): 27 October 2025
Q3 FY27 results due by: 14 February 2027

Q2 FY27 at a glance · consolidated

Net profit: ₹157 Cr−11.5% vs Q2 FY26−26.8% vs Q1 FY27
Revenue from operations: ₹907 Cr−2.4% vs Q2 FY26−14.7% vs Q1 FY27
Operating margin (EBIT): 18.6%−3.1 pts vs Q2 FY26−1.7 pts vs Q1 FY27EBIT ₹169 Cr
EBITDA: ₹186 Cr−14.8% vs Q2 FY26−20.4% vs Q1 FY27margin 20.5%
Earnings per share (basic): ₹3.14−11.8% vs Q2 FY26−27.0% vs Q1 FY27
Net profit margin: 17.3%−1.8 pts vs Q2 FY26−2.9 pts vs Q1 FY27

Questions

What was Sumitomo Chemical India's net profit in Q2 FY27?

Consolidated net profit was ₹157 crore, down 11.5% from ₹178 crore in Q2 FY26 and down 26.8% from ₹215 crore in Q1 FY27.

What was Sumitomo Chemical India's revenue in Q2 FY27?

Revenue from operations was ₹907 crore, down 2.4% year on year and down 14.7% from the previous quarter.

What was Sumitomo Chemical India's operating margin in Q2 FY27?

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹169 crore, a margin of 18.6%, against 20.3% in Q1 FY27 and 21.6% in Q2 FY26. EBITDA was ₹186 crore, 20.5% of revenue.

How were Sumitomo Chemical India's Q2 FY27 results?

Both fell from a year earlier: net profit was down 11.5% at ₹157 crore and revenue was down 2.4% at ₹907 crore. The operating margin was 18.6%, down 3.1 percentage points from 21.6% a year earlier. Against Q1 FY27, net profit was down 26.8% and revenue down 14.7%.

What was Sumitomo Chemical India's net profit in the first half of FY27?

Consolidated net profit for the first half of FY27 (April–September 2026) was ₹372 crore, up 4.5% from ₹356 crore in the same months a year earlier. Revenue from operations was ₹1,971 crore, down 0.8%.

What was Sumitomo Chemical India's revenue in FY26?

Revenue from operations was ₹3,238 crore in FY26 (April 2025–March 2026), up 2.9% from ₹3,149 crore in FY25. It was ₹2,844 crore in FY24 and ₹3,511 crore in FY23: down 7.8% over three years, an average fall of 2.7% a year.

What was Sumitomo Chemical India's EPS in Q2 FY27?

Basic earnings per share were ₹3.14, against ₹3.56 in Q2 FY26.

What is Sumitomo Chemical India's net profit margin?

Sumitomo Chemical India's net profit margin was 17.3% in Q2 FY27 (net profit as a share of revenue from operations), against 19.1% in Q2 FY26 (down 1.8 percentage points). For FY26 as a whole it was 16.8%.

When did Sumitomo Chemical India announce its Q2 FY27 results?

On Monday, 26 October 2026 at 3:50 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 27 October 2025.

How has Sumitomo Chemical India's profit changed over the last four quarters?

Net profit by quarter: ₹75.6 crore in Q3 FY26, ₹111 crore in Q4 FY26, ₹215 crore in Q1 FY27 and ₹157 crore in Q2 FY27. That is ₹559 crore over the four quarters, up 3.0% from ₹543 crore in the four quarters before. Revenue from operations: ₹568 crore, ₹684 crore, ₹1,063 crore and ₹907 crore.

What was Sumitomo Chemical India's net profit in FY26?

Consolidated net profit was ₹543 crore in FY26 (April 2025–March 2026), up 7.4% from ₹505 crore in FY25. It was ₹370 crore in FY24 and ₹502 crore in FY23: up 8.1% over three years, 2.6% a year on average.

When will Sumitomo Chemical India announce its Q3 FY27 results?

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Where do these Sumitomo Chemical India figures come from?

From Sumitomo Chemical India's own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 26 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.